Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5 Pt 1
pubmed:dateCreated
1993-6-22
pubmed:abstractText
To determine the tissue localization of insulin resistance in type 1 diabetic patients, whole body and regional glucose uptake rates were determined under euglycemic hyperinsulinemic conditions. Leg, arm, and heart glucose uptake rates were measured using positron emission tomography-derived 2-deoxy-2-[18F]-fluoro-D-glucose kinetics and the three-compartment model described by Sokoloff et al. (L. Sokoloff, M. Reivich, C. Kennedy, M.C. DesRosiers, C.S. Patlak, K.D. Pettigrew, O. Sakurada, and M. Shinohara. J. Neurochem. 28: 897-916, 1977) in eight type 1 diabetic patients and eight matched normal subjects. Whole body glucose uptake was quantitated by the euglycemic insulin clamp technique. Whole body glucose uptake was approximately 31% lower in the diabetic patients (P < 0.01) than in the normal subjects, thus confirming the presence of whole body insulin resistance. The rate of glucose uptake was approximately 45% lower in leg muscle when measured in the femoral region (55 +/- 7 vs. 102 +/- 13 mumol.kg muscle-1.min-1, diabetic patients vs. normal subjects, P < 0.05) and approximately 27% lower in the arm muscles (66 +/- 4 vs. 90 +/- 13 mumol.kg muscle-1.min-1, respectively, P < 0.05), whereas no difference was observed in heart glucose uptake [789 +/- 80 vs. 763 +/- 58 mumol.kg muscle-1.min-1 not significant (NS)]. Whole body glucose uptake correlated with glucose uptake in femoral (r = 0.93, P < 0.005) and arm muscles (r = 0.66, P < 0.05) but not with glucose uptake in the heart (r = 0.04, NS). We conclude that insulin resistance in type 1 diabetic patients is localized to skeletal muscle, whereas heart glucose uptake is unaffected.(ABSTRACT TRUNCATED AT 250 WORDS)
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0002-9513
pubmed:author
pubmed:issnType
Print
pubmed:volume
264
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
E756-62
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:8498497-Adult, pubmed-meshheading:8498497-Blood Glucose, pubmed-meshheading:8498497-C-Peptide, pubmed-meshheading:8498497-Deoxyglucose, pubmed-meshheading:8498497-Diabetes Mellitus, Type 1, pubmed-meshheading:8498497-Fluorine Radioisotopes, pubmed-meshheading:8498497-Fluorodeoxyglucose F18, pubmed-meshheading:8498497-Glucose, pubmed-meshheading:8498497-Glucose Clamp Technique, pubmed-meshheading:8498497-Heart, pubmed-meshheading:8498497-Hemoglobin A, Glycosylated, pubmed-meshheading:8498497-Humans, pubmed-meshheading:8498497-Infusions, Intravenous, pubmed-meshheading:8498497-Insulin, pubmed-meshheading:8498497-Insulin Resistance, pubmed-meshheading:8498497-Muscles, pubmed-meshheading:8498497-Myocardium, pubmed-meshheading:8498497-Organ Specificity, pubmed-meshheading:8498497-Reference Values, pubmed-meshheading:8498497-Tomography, Emission-Computed
pubmed:year
1993
pubmed:articleTitle
Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes.
pubmed:affiliation
Department of Medicine, Turku Medical Cyclotron-Positron Emission Tomography Center, University of Turku, Finland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't